Reach Us +441234923305


Paula A Witt-Enderby | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Paula A Witt-Enderby

Division of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, USA


Paula-Witt-Enderby is affiliated to Division of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, USA. She is a translational research scientist who performs both basic science and clinical research in the area of melatonin. My objectives are to improve human health by developing safe, alternative therapies for people to take with a focus on menopause and menopause-related diseases like osteoporosis and breast cancer. She has completed her Ph.D in Pharmacology and Toxicology.

Alternative Options to Manage Menopausal Symptoms with a Focus on Melatonin and Osteoporosis

Many menopausal women are seeking symptomatic relief from hot flushes, irritability, sleep disturbances, anxiety and depression, and to prevent bone loss. Instead of pharmaceutical approaches, many women are opting for alternative modalities such as yoga, meditation and natural products. Melatonin is a molecule released from the pineal gland in res... Read More»

Holly Lassila, Nutjaree Pratheepawanit Johns, Christine K O’Neil, Jeffrey R Johns, Judith L Balk and Paula A Witt-Enderby

Review Article: Clin Pharmacol Biopharm 2014, 3:115

DOI: 10.4172/2167-065X.1000115

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF